Literature DB >> 7634433

Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.

S M Shanley1, G Chenevix-Trench, J Palmer, N Hayward.   

Abstract

The GSTM1 gene on chromosome 1p encodes the carcinogen-detoxification enzyme, glutathione S-transferase (mu subclass). The homozygous null genotype at this locus has been associated with increased susceptibility to malignancy, including some skin cancers. One hundred and twenty-four Australian patients with sporadic melanoma and 62 with familial basal cell carcinomas (a feature of nevoid basal cell carcinoma syndrome, NBCCS) were examined for germline homozygous deletions of GSTM1 using multiplex polymerase chain reactions. The homozygous null genotype was not overrepresented in either those with a single melanoma or in the NBCCS cases. Nor did it significantly accelerate tumorigenesis in either group. Analyses of much larger sample sizes will be required to investigate the representation of the null genotype in patients with multiple melanoma primaries and in those with melanoma co-existing with other non-cutaneous malignancies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634433     DOI: 10.1093/carcin/16.8.2003

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer.

Authors:  F Bardakci; E Canbay; Naci Degerli; L Coban; E I Canbay
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

3.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

4.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27

5.  Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  Abdul K Siraj; Muna Ibrahim; Maha Al-Rasheed; Jehad Abubaker; Rong Bu; Shakaib U Siddiqui; Fouad Al-Dayel; Osama Al-Sanea; Abdulrahman Al-Nuaim; Shahab Uddin; Khawla Al-Kuraya
Journal:  BMC Med Genet       Date:  2008-07-05       Impact factor: 2.103

6.  Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia.

Authors:  Jiangnan Pei; Zhenzhen Liu; Chengjie Wang; Nan Chu; Lei Liu; Yao Tang; Haiyan Liu; Qianqian Xiang; Haidong Cheng; Mingqing Li; Weirong Gu
Journal:  Biomolecules       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.